|
|
|
Insider
Information: |
Chang Nancy T |
Relationship: |
Director |
City: |
Houston |
State: |
TX |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
3,873,860 |
|
Indirect Shares
|
2,715,130 |
|
|
Direct
Value |
$5,871,444 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
6,588,990 |
|
|
Total
Value |
$5,871,444 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Tanox Inc |
TNOX |
Director, 10% Owner |
2006-11-06 |
3,661,879 |
2006-05-05 |
2,715,130 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Apex Bioventures Acquisition Corp |
PEX.WS |
Director |
2007-06-07 |
183,951 |
|
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Charles River Laboratories Inter... |
CRL |
Director |
2009-05-08 |
28,030 |
2008-02-22 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Sciclone Pharmaceuticals Inc |
SCLN |
Director |
2017-10-13 |
0 |
2016-08-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
58 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SCLN |
Sciclone Pharmaceuticals ... |
Director |
|
2014-08-15 |
4 |
B |
$6.00 |
$150,222 |
I/I |
25,040 |
25,040 |
2.1 |
- |
|
SCLN |
Sciclone Pharmaceuticals ... |
Director |
|
2015-02-12 |
4 |
OE |
$5.10 |
$149,997 |
D/D |
29,019 |
54,059 |
0 |
- |
|
SCLN |
Sciclone Pharmaceuticals ... |
Director |
|
2016-08-26 |
4 |
S |
$10.25 |
$76,891 |
I/I |
(7,500) |
17,540 |
0 |
- |
|
SCLN |
Sciclone Pharmaceuticals ... |
Director |
|
2016-08-29 |
4 |
S |
$10.31 |
$103,119 |
I/I |
(10,000) |
7,540 |
0 |
- |
|
SCLN |
Sciclone Pharmaceuticals ... |
Director |
|
2016-08-30 |
4 |
S |
$10.33 |
$77,887 |
I/I |
(7,540) |
0 |
0 |
- |
|
SCLN |
Sciclone Pharmaceuticals ... |
Director |
|
2016-09-29 |
4 |
OE |
$5.10 |
$213,003 |
D/D |
40,981 |
70,000 |
0 |
- |
|
SCLN |
Sciclone Pharmaceuticals ... |
Director |
|
2017-10-13 |
4 |
D |
$11.18 |
$782,600 |
D/D |
(70,000) |
0 |
0 |
- |
|
PEX.WS |
Apex Bioventures Acquisit... |
Director |
|
2007-06-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
183,951 |
|
- |
|
58 Records found
|
|
Page 3 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|